For instance, younger patients (≤ 50 years) exhibited a stronger prognostic association (HR 0.61; 95% CI: 0.40–0.94) compared to older patients (> 50 years), who showed a nonsignificant trend (HR 0.62; 95% CI: 0.37–1.05) with higher heterogeneity (I2 = 66%).
← all excerpts
Prognostic significance of CD8 + tumor-infiltrating lymphocytes in operable breast cancer: a meta-analysis.
1
—
—